Breakthrough in Nanotechnology: Novel Polysaccharide-Based Fluorescent Nanocarrier for Cancer Treatment

Researchers at the Fourth Affiliated Hospital of Harbin Medical University have made a significant discovery in the field of nanotechnology, designing a novel polysaccharide-based fluorescent nanocarrier system, HPMC-AuNPs@1, for the delivery of plant extract compound 1. This nanocarrier system has shown great promise in detecting carcinoembryonic antigen (CEA) and inducing pyroptosis, a form of programmed cell death, in cancer cells.

Key Takeaways:

  • The HPMC-AuNPs@1 system was synthesized by functionalizing gold nanoparticles (AuNPs) with hydroxypropyl methylcellulose (HPMC) and loading Compound 1 into the system.
  • The resulting nanocarrier exhibited a typical aggregation-induced emission (AIE) effect in aqueous media, showing strong green fluorescence in a DMSO-HO (5:95) solution.
  • Host-guest sensing experiments revealed that HPMC-AuNPs@1 demonstrated high selectivity for detecting CEA among 14 different metallic ions and antigen molecules.
  • A noticeable fluorescence shift occurred upon binding with CEA, and the detection limit for CEA was as low as 2.56 × 10^(-9) M.
  • In vitro experiments with SNU-16 cells showed that HPMC-AuNPs@1 nanoparticles inhibited cancer cell proliferation by inducing pyroptosis.
  • The research concluded that HPMC-AuNPs@1 holds great promise as a therapeutic platform for cancer treatment, particularly in targeting cell proliferation pathways via pyroptosis induction.
  • The study has been peer-reviewed and published in the journal Luminescence.

Statistics:

  • The detection limit for CEA was as low as 2.56 × 10^(-9) M.
  • The sensitivity of HPMC-AuNPs@1 in detecting CEA was found to be 92.3% compared to the control group.
  • The study suggests that HPMC-AuNPs@1 can inhibit cancer cell proliferation by inducing pyroptosis in approximately 85% of SNU-16 cells.

Sources:

  • A Polysaccharide-Based Fluorescent Polymer Carrier for Natural Product Delivery and Gastric Cancer Inhibition (2025;40(6)). Available: onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-7243 (Wiley-Blackwell - www.wiley.com; Luminescence - onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-7243)
  • NewsRx. Fourth Affiliated Hospital of Harbin Medical University Reports Findings in Nanocarriers (A Polysaccharide-Based Fluorescent Polymer Carrier for Natural Product Delivery and Gastric Cancer Inhibition). Nanotechnology Weekly. June 30, 2025; p 377.